AKT1 and non-small cell lung carcinoma: Previous studies have reported increased activation of the EGFR/PI3K/AKT signal transduction pathway in EGFR-TKI-resistant NSCLC cells, and this activation promotes cell proliferation and suppresses the apoptosis of cancer cells [39,40,48,49].